Patent details

EP2295409 Title: FLUORO SUBSTITUTED CYCLOALKANOINDOLES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS

Basic Information

Publication number:
EP2295409
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101824639
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FLUORO SUBSTITUTED CYCLOALKANOINDOLES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
French Title of Invention:
CYCLOALKANOINDOLES SUBSTITUÉS PAR UN FLUOR ET LEUR UTILISATION COMME ANTAGONISTES DU RÉCEPTEUR DE PROSTAGLANDINE D2
German Title of Invention:
FLUORO SUBSTITUIERTE CYCLOALKANINDOLE UND DEREN VERWENDUNG ALS PROSTAGLANDIN D2 REZEPTOR ANTAGONISTEN
SPC Number:

Dates

Filing date:
22/01/2003
Grant date:
02/07/2014
EP Publication Date:
02/07/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/03/2011
EP B1 Publication Date:
02/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/01/2015
Expiration date:
22/01/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/01/2003
 
 

Name:
Merck Canada Inc.
Address:
16711 Trans-Canada Highway, Kirkland, QC H9H 3L1, Canada (CA)

Inventor

1

Name:
Lachance Nicolas
Address:
Canada (CA)

2

Name:
Wang Zhaoyin
Address:
Canada (CA)

3

Name:
Sturino Claudio
Address:
Canada (CA)

4

Name:
Berthelette Carl
Address:
Canada (CA)

5

Name:
Li Lianhai
Address:
Canada (CA)

Priority

Priority Number:
351384 P
Priority Date:
24/01/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 209/80;
Filing date Document type Number of pages